N,3-Dimethyl-1,2,4-oxadiazol-5-amine, 97%, 100mg

n-Methyl-n-phenylprop-2-enamide, 95%, 10g

(S)-2-(3-Bromophenyl)pyrrolidine hydrochloride, 95.0%, 250mg

16-Mercaptohexadecanoic acid, 98.0%, 250mg

Phenosafranine, 98%, 25g

4-[2-({[(9h-fluoren-9-yl)methoxy]carbonyl}amino)ethoxy]benzoic acid, 97%, 5g

(R)-2-Methyl-1-phenylpropan-1-amine hydrochloride, 95.0%, 1g

(S)-2-((tert-Butoxycarbonyl)amino)-2-(naphthalen-2-yl)acetic acid, 97.0%, 250mg

4-Ethoxy-3-hydroxymethyl-benzaldehyde, 95.0%, 1g

Dibromomethane (stabilized with BHT)>99.0%(GC)25g

D-arginine monohydrochloride, min. 99%, for biochemistry, 25 g, plastic packaging.

N-methyl-1-(4-methyl-1,3-thiazol-2-yl)methanamine, 95.0%, 5g

3-(Difluoromethoxy)iodobenzene, 95.0%, 1g